… showing more bipartisan support for patent reform than for government price controls … drug prices, showing they favor patent reform over government price controls (65% … targeted regulatory interventions," with patent reform standing out as a particularly …

This article is part of the Life Sciences Industry 2025 Market Update. Click here to read the full newsletter. Though largely absent from mainstream news, proposed reforms to patent law are poised to affect everything from biotech startups to major …

Hoping to support pharmaceutical innovation and competitiveness, Stockholm is advocating for a Unitary Patent System. Sweden is one of eleven EU Member States pushing the Danish Presidency to finalise an EU system for enhanced patent protection for …

… innovation, echoing broader discussions on patent reform. Legal experts, including those cited …

… can only be reversed through patent reform, Schultz argues. BIO supports legislative … ’s conference The need for patent reform to address the negative impact …

A bipartisan group of senators and congressional representatives reintroduced the Patent Eligibility Restoration Act (PERA), which aims to reform the law of patent eligibility under 35 U.S.C. § 101. PERA seeks to address the challenges posed by recent …

The May 1 reintroduction of two bills designed to strengthen the certainty of U.S. patents earned praise from the Biotechnology Innovation Organization (BIO). The Patent Eligibility Restoration Act (PERA Act) would address confusing court decisions by …

… on calls for pharmaceutical patent reform for a while. … nonprofit organization that advocates drug patent reform, says that “excessive” … pharmaceutical industry maintains that patent reform isn’t needed. It … on two bipartisan drug patent reform bills in the …

… of USPTO Director Vidal, pharmaceutical patent reform is likely on the minds … to this political transition, pharmaceutical patent reform garnered renewed attention in the …